Related references
Note: Only part of the references are listed.Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma
Marie Morfouace et al.
CANCER CELL (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma
Timea Pocza et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
MicroRNAs MiR-218, MiR-125b, and Let-7g Predict Prognosis in Patients with Oral Cavity Squamous Cell Carcinoma
Shih-Chi Peng et al.
PLOS ONE (2014)
PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
Jing Tan et al.
CANCER DISCOVERY (2013)
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma
Anton Henssen et al.
ONCOTARGET (2013)
Role of MYC in Medulloblastoma
Martine F. Roussel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Oncostatin M Is a Growth Factor for Ewing Sarcoma
Emmanuelle David et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Role of Epidermal Growth Factor-Triggered PI3K/Akt Signaling in the Migration of Medulloblastoma-Derived Cells
Veronica Dudu et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2012)
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
Lori S. Hart et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Gene Signatures Associated with Mouse Postnatal Hindbrain Neural Stem Cells and Medulloblastoma Cancer Stem Cells Identify Novel Molecular Mediators and Predict Human Medulloblastoma Molecular Classification
Daniela Corno et al.
CANCER DISCOVERY (2012)
Childhood medulloblastoma
Maura Massimino et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors
K. Hoeland et al.
CURRENT CANCER DRUG TARGETS (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110γ Isoform in Medulloblastoma Cell Proliferation and Chemoresistance
Ana S. Guerreiro et al.
MOLECULAR CANCER RESEARCH (2011)
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma
G. Fiaschetti et al.
ONCOGENE (2011)
The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
Sarah Ball et al.
PLOS ONE (2011)
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
Nina Ilic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Two common SNPs in pri-miR-125a alter the mature miRNA expression and associate with recurrent pregnancy loss in a Han-Chinese population
Yi Hu et al.
RNA BIOLOGY (2011)
Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/beta-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth
Ninib Baryawno et al.
CANCER RESEARCH (2010)
Silencing of Thrombospondin-1 Is Critical for Myc-Induced Metastatic Phenotypes in Medulloblastoma
Limei Zhou et al.
CANCER RESEARCH (2010)
p53 regulates LIF expression in human medulloblastoma cells
Euan W. Baxter et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The Quassinoid Derivative NBT-272 Targets Both the AKT and ERK Signaling Pathways in Embryonal Tumors
Deborah Castelletti et al.
MOLECULAR CANCER THERAPEUTICS (2010)
RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells
Andre O. von Bueren et al.
BMC CANCER (2009)
Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Michael A. Grotzer et al.
CURRENT CANCER DRUG TARGETS (2009)
MicroRNA profiling in human medulloblastoma
Elisabetta Ferretti et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Tsung-Cheng Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
Ana S. Guerreiro et al.
CLINICAL CANCER RESEARCH (2008)
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
Elisabetta Ferretti et al.
EMBO JOURNAL (2008)
N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma
J. Kang et al.
ONCOGENE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
Chi-Hwa Wu et al.
PLOS GENETICS (2008)
Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death
Hong-Gang Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Leukemia inhibitory factor: A newly identified metastatic factor in rhabdomyosarcomas
Marcin Wysoczynski et al.
CANCER RESEARCH (2007)
Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells
Andre O. von Bueren et al.
BMC CANCER (2007)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
S Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
c-Myc overexpression causes anaplasia in medulloblastoma
D Stearns et al.
CANCER RESEARCH (2006)
Accessing key steps of human tumor progression in vivo by using an avian embryo model
M Hagedorn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas
DK Broderick et al.
CANCER RESEARCH (2004)
Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors
AM Kenney et al.
DEVELOPMENT (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Paediatric embryonic brain tumours: biological and clinical relevance of molecular genetic abnormalities
R Gilbertson
EUROPEAN JOURNAL OF CANCER (2002)
The developmental biology of brain tumors
R Wechsler-Reya et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Share Paper
